No photo of Ali Shilatifard

View Scopus Profile

Ali Shilatifard

  • 22264 Citations
1991 …2024

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

PhD, University of Oklahoma

… → 1994

Fingerprint Dive into the research topics where Ali Shilatifard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 38 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

A molecular informed therapy for Diffuse Intrinsic Pontine Gliomas (DIPG)

Shilatifard, A.

National Cancer Institute

9/15/19 → 8/31/21

Project: Research project

    • Super Elongation Complex Disruptors for Cancer Therapeutics

    Shilatifard, A.

    Lakeside Discovery, LLC

    4/15/19 → 4/14/24

    Project: Research project

    • Exploring novel regulatory mechanisms underlying enhancer activation and cell fate transition

    Shilatifard, A.

    National Institute of Child Health and Human Development

    3/11/19 → 2/28/21

    Project: Research project

    • Structure and Function of the SS18-SSX-containing mSWI/SNF (BAF) Complex Unveiling New Paths Toward Therapeutic Targeting

    Shilatifard, A. & Morgan, M. A.

    Dana-Farber Cancer Institute, National Cancer Institute

    9/18/18 → 6/30/23

    Project: Research project

    Epigenetic Regulation by Histone Modifiers in Development and Cancer

    Shilatifard, A.

    National Cancer Institute

    9/7/18 → 8/31/20

    Project: Research project

    • Research Output

    A non-canonical monovalent zinc finger stabilizes the integration of Cfp1 into the H3K4 methyltransferase complex COMPASS

    Yang, Y., Joshi, M., Takahashi, Y. H., Ning, Z., Qu, Q., Brunzelle, J. S., Skiniotis, G., Figeys, D., Shilatifard, A. & Couture, J. F., Jan 10 2020, In : Nucleic acids research. 48, 1, p. 421-431 11 p.

    Research output: Contribution to journal › Article

    Open Access

    • Catacomb: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism

    Piunti, A., Smith, E. R., Morgan, M. A. J., Ugarenko, M., Khaltyan, N., Helmin, K. A., Ryan, C. A., Murray, D. C., Rickels, R. A., Yilmaz, B. D., Rendleman, E. J., Savas, J. N., Singer, B. D., Bulun, S. E. & Shilatifard, A., Jan 1 2019, In : Science Advances. 5, 7, eaax2887.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    Correction: Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes (Oncotarget (2018) 9 (37112-37124) DOI: 10.18632/oncotarget.26430)

    Huang, T., Garcia, R., Qi, J., Lulla, R., Horbinski, C. M., Behdad, A., Wadhwani, N. R., Shilatifard, A., James, C. D. & Saratsis, A. M., Apr 12 2019, In : Oncotarget. 10, 28, 1 p.

    Research output: Contribution to journal › Comment/debate

    Open Access

    • Correction to: Aberrant activation of non-coding RNA targets of transcriptional elongation complexes contributes to TDP-43 toxicity (Nature Communications, (2018), 9, 1, (4406), 10.1038/s41467-018-06543-0)

    Chung, C. Y., Berson, A., Kennerdell, J. R., Sartoris, A., Unger, T., Porta, S., Kim, H. J., Smith, E. R., Shilatifard, A., Van Deerlin, V., Lee, V. M. Y., Chen-Plotkin, A. & Bonini, N. M., Dec 1 2019, In : Nature communications. 10, 1, 555.

    Research output: Contribution to journal › Comment/debate

    • Epigenetic modifications of histones in cancer

    Zhao, Z. & Shilatifard, A., Nov 20 2019, In : Genome biology. 20, 1, 245.

    Research output: Contribution to journal › Review article

    Open Access
    • 6 Scopus citations